Q3 FY2026 · ended Jun 30, 2026 · Revenue $4.98B, +5.4% YoY · Filed Aug 6, 2026
Becton, Dickinson And Company (BDX) files with the SEC under industry code 3841, Surgical & Medical Instruments & Apparatus. In Q3 of fiscal 2026, the quarter ended Jun 30, 2026, it reported revenue of $5.0 billion and net income of $377.0 million. Free cash flow was $633.0 million. As of Jun 30, 2026 it held $708.0 million in cash and investments and $13.5 billion in total debt.
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- BDX (NYSE)
- Fiscal year ends
- September 30
- Incorporated in
- NJ
- Headquarters
- Franklin Lakes, NJ
- SEC filer status
- Large accelerated filer
- SEC CIK
- 10795
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
- West Pharmaceutical Services Inc WST
All 151 Surgical & Medical Instruments & Apparatus companies
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q3 FY2026 Jun 30, 2026 |
Q2 FY2026 Mar 31, 2026 |
Q1 FY2026 Dec 31, 2025 |
Q4 FY2025 Sep 30, 2025 |
Q3 FY2025 Jun 30, 2025 |
|---|---|---|---|---|---|
| Revenue | $5.0B | $4.7B | $5.3B | $8.3B | $4.7B |
| Operating income | $663.0M | $93.0M | $552.0M | $1.2B | $739.0M |
| Net income | $377.0M | -$311.0M | $382.0M | $493.0M | $574.0M |
| Diluted EPS | $1.37 | -$1.11 | $1.34 | $1.71 | $2.00 |
| Operating cash flow | $776.0M | $1.3B | — | $1.9B | $1.1B |
| Free cash flow | $633.0M | $1.2B | — | $1.5B | $925.0M |
| Total assets | $50.7B | $50.8B | $54.8B | $55.3B | $54.9B |
| Stockholders' equity | $24.4B | $24.1B | $25.3B | $25.4B | $25.5B |
| Cash and investments | $708.0M | $813.0M | $740.0M | $567.0M | $735.0M |
| Total debt | $13.5B | $14.7B | $16.9B | $18.5B | $17.5B |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Results of operations
|
Nov 5, 2026 | Nov 5, 2026 |
| 10-Q | Quarterly report | Aug 6, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2026 | Aug 6, 2026 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jul 22, 2026 | Jul 19, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
May 29, 2026 | May 29, 2026 |
| 8-K |
Current report
Material agreement, New debt
|
May 20, 2026 | May 20, 2026 |
All 1003 Becton, Dickinson And Company SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.